ViroMissile
La Jolla, US · Delaware corporation
Founders & leadership
MB
Mark BertagnolliExecutive
NG
Nanhai G. ChenNamed on SEC filing
WZ
Weili ZhouNamed on SEC filing
Board
TZ
Tianyu ZhouBoard director
RB
Rolf BenirschkeBoard director
DW
Douglas WallBoard director
Reported raises · per SEC filings
Form D private placements$550K disclosed across 2 rounds · 2023–2025
▶$500KraisedJun 2025 · 5 investors · BiotechnologyRule 506(b)
▶$500KraisedJun 2025 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rolf BenirschkeDirector
- Douglas WallDirector
- Mark BertagnolliExecutive Officer, Director
- Nanhai G. ChenExecutive Officer, Director
- Tianyu ZhouDirector
- Offering amount
- $15M
- Amount sold
- $500K
- Minimum investment
- $100K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$50KraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Weili ZhouDirector
- Nanhai G. ChenExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $50K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has ViroMissile raised?
- ViroMissile has disclosed $550K raised across 2 rounds.
- Where is ViroMissile headquartered?
- ViroMissile is headquartered in La Jolla, US.